Is high iron levels a sign of cancer?

High iron levels can sometimes indicate cancer, particularly blood cancers, liver cancer, or metastatic disease, but they're more commonly caused by genetic conditions, liver disease, or excessive supplementation. If you have elevated iron levels, comprehensive testing including ferritin, transferrin saturation, and other biomarkers is essential for proper diagnosis.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Connection Between High Iron and Cancer

Finding out you have high iron levels can be concerning, especially when you start researching potential causes and cancer appears on the list. While elevated iron can sometimes be associated with certain cancers, it's important to understand that many other conditions are more likely culprits. Iron is an essential mineral that your body needs for producing red blood cells, supporting immune function, and maintaining overall health. However, too much iron can be harmful and may signal an underlying health issue that needs attention.

The relationship between iron and cancer is complex. Some cancers can cause iron levels to rise, while in other cases, excess iron may contribute to cancer development. However, before jumping to conclusions, it's crucial to understand that elevated iron levels are more commonly caused by genetic conditions like hemochromatosis, liver disease, frequent blood transfusions, or excessive iron supplementation. Getting comprehensive testing can help determine the actual cause of your elevated iron levels.

How Cancer Can Affect Iron Levels

Certain types of cancer can indeed cause iron levels to rise, though the mechanisms vary. Blood cancers like leukemia, lymphoma, and multiple myeloma can directly affect iron metabolism by disrupting normal blood cell production and turnover. When cancer cells multiply rapidly, they can release iron from damaged cells into the bloodstream, leading to elevated serum iron levels.

Common Causes of Elevated Iron Levels

This table shows the relative frequency and distinguishing features of conditions causing high iron levels.
ConditionFrequencyKey FeaturesTreatment Approach
HemochromatosisHereditary Hemochromatosis1 in 200-300Genetic mutation, family history, joint painPhlebotomy, blood donation
Liver DiseaseLiver DiseaseVery commonElevated liver enzymes, fatigue, jaundiceTreat underlying liver condition
CancerCancerUncommonWeight loss, night sweats, lymph node swellingCancer-specific treatment
SupplementationExcess SupplementationCommonHistory of iron supplement useStop supplements, monitor levels

This table shows the relative frequency and distinguishing features of conditions causing high iron levels.

Liver cancer is another malignancy strongly associated with high iron levels. Since the liver is the primary organ for iron storage and regulation, tumors in the liver can disrupt normal iron metabolism. Additionally, many liver cancers develop in patients who already have underlying liver disease, which itself can cause iron accumulation. Metastatic cancers that spread to the liver can also interfere with iron regulation.

Some solid tumors can produce substances that affect iron metabolism. For instance, certain cancers release inflammatory cytokines that can alter how the body processes and stores iron. This can lead to a condition called anemia of chronic disease, where iron gets trapped in storage sites and isn't available for red blood cell production, sometimes resulting in paradoxically high ferritin levels despite functional iron deficiency.

Common Non-Cancer Causes of High Iron

Before assuming cancer is the cause of elevated iron levels, it's important to consider more common explanations. Understanding these alternatives can help put your mind at ease and guide appropriate testing and treatment decisions.

Hereditary Hemochromatosis

Hereditary hemochromatosis is the most common genetic cause of iron overload, affecting approximately 1 in 200-300 people of Northern European descent. This condition causes your body to absorb too much iron from food, leading to accumulation in organs like the liver, heart, and pancreas. If left untreated, it can cause serious complications, but when caught early, it's highly manageable through regular blood removal (phlebotomy) or blood donation.

Liver Disease

Various liver conditions can cause elevated iron levels, including alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), hepatitis B and C, and cirrhosis. The liver plays a crucial role in iron metabolism, producing hepcidin, the hormone that regulates iron absorption. When the liver is damaged, this regulation can be disrupted, leading to iron accumulation.

Other Common Causes

  • Excessive iron supplementation or frequent use of iron-containing vitamins
  • Multiple blood transfusions for conditions like thalassemia or sickle cell disease
  • Inflammatory conditions that can elevate ferritin levels
  • Metabolic syndrome and insulin resistance
  • Hyperthyroidism
  • Certain medications that affect iron metabolism

Key Iron Biomarkers and What They Mean

Understanding your iron status requires looking at multiple biomarkers, not just a single test. Each marker provides different information about how your body is processing and storing iron. Here are the key tests used to evaluate iron levels:

Ferritin

Ferritin is the primary storage form of iron in your body and often the first marker to become elevated in iron overload. Normal ranges vary by lab and gender, but generally fall between 12-150 ng/mL for women and 12-300 ng/mL for men. However, ferritin is also an acute-phase reactant, meaning it can be elevated due to inflammation, infection, or cancer even without true iron overload. This is why additional testing is crucial for accurate diagnosis.

Serum Iron and Transferrin Saturation

Serum iron measures the amount of iron circulating in your blood, while transferrin saturation indicates what percentage of the iron-transport protein transferrin is carrying iron. Transferrin saturation above 45% is often used as a screening threshold for hemochromatosis. These markers can fluctuate throughout the day and with meals, so fasting tests are typically recommended.

Total Iron Binding Capacity (TIBC)

TIBC measures the blood's capacity to bind iron with transferrin. In iron overload conditions, TIBC is often low or normal, while in iron deficiency, it's typically elevated. The relationship between serum iron and TIBC helps clinicians understand whether high ferritin is due to true iron overload or other causes.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Symptoms of High Iron Levels

Early iron overload often causes no symptoms, which is why many cases go undiagnosed until organ damage occurs. When symptoms do appear, they can be vague and easily attributed to other conditions. Common early symptoms include:

  • Chronic fatigue and weakness
  • Joint pain, particularly in the hands
  • Abdominal pain
  • Loss of sex drive or erectile dysfunction
  • Irregular menstrual periods or early menopause
  • Brain fog or difficulty concentrating
  • Mood changes, including depression or irritability

As iron accumulation progresses, more serious symptoms can develop, including skin darkening (bronze or gray discoloration), diabetes due to pancreatic damage, heart problems including arrhythmias and heart failure, liver enlargement and cirrhosis, and arthritis. These advanced symptoms underscore the importance of early detection and treatment.

When to Seek Medical Attention

If you have elevated iron levels, especially ferritin above 300 ng/mL or transferrin saturation above 45%, it's important to consult with a healthcare provider. They can help determine whether your high iron is due to a benign cause or something more serious. Red flags that warrant immediate medical attention include:

  • Unexplained weight loss
  • Persistent abdominal pain or swelling
  • Yellowing of the skin or eyes (jaundice)
  • Severe fatigue that interferes with daily activities
  • New-onset diabetes without other risk factors
  • Heart palpitations or chest pain
  • Significant changes in skin color

Your doctor may recommend additional testing, including genetic testing for hemochromatosis, liver function tests, imaging studies like ultrasound or MRI to assess organ iron content, and potentially cancer screening if other causes have been ruled out. Regular monitoring of your iron levels can help track changes over time and guide treatment decisions.

Testing and Diagnosis

Proper diagnosis of high iron levels requires a systematic approach. Initial screening typically includes a complete iron panel with ferritin, serum iron, TIBC, and transferrin saturation. If these tests confirm iron overload, genetic testing for hemochromatosis mutations (HFE gene) is often the next step. Additional tests may include liver enzymes to assess liver health, fasting glucose to check for diabetes, and inflammatory markers like C-reactive protein to rule out inflammation as a cause of elevated ferritin.

For those concerned about their iron levels or wanting to monitor their metabolic health comprehensively, at-home testing provides a convenient option. Understanding your baseline levels and tracking changes over time can help you and your healthcare provider make informed decisions about your health. If you're interested in analyzing your existing blood test results, you can use SiPhox Health's free upload service to get personalized insights and recommendations based on your iron biomarkers and other health data.

Treatment and Management Strategies

Treatment for high iron levels depends entirely on the underlying cause. For hereditary hemochromatosis, therapeutic phlebotomy (blood removal) is the gold standard treatment. Initially, blood may be removed weekly until iron levels normalize, then maintenance phlebotomy every 2-4 months keeps levels stable. Many patients find that regular blood donation serves the dual purpose of managing their condition while helping others.

Dietary modifications can help manage iron levels, though diet alone is rarely sufficient for significant iron overload. Key dietary strategies include limiting red meat consumption, avoiding iron-fortified foods, reducing vitamin C intake with meals (as it enhances iron absorption), avoiding raw shellfish (due to infection risk in iron overload), limiting alcohol consumption, and drinking tea or coffee with meals (tannins reduce iron absorption).

For iron overload due to other causes, treatment focuses on addressing the underlying condition. This might include treating liver disease, managing inflammatory conditions, adjusting medications, or in cases where phlebotomy isn't possible, using iron chelation therapy. Regular monitoring ensures treatment effectiveness and helps prevent complications.

The Bottom Line on Iron and Cancer Risk

While high iron levels can occasionally indicate cancer, particularly blood cancers or liver malignancies, they're much more commonly caused by genetic conditions, liver disease, or other benign factors. The key is not to panic but to pursue appropriate testing to determine the cause. Early detection and treatment of iron overload, regardless of the cause, can prevent serious complications and improve long-term health outcomes.

If you have elevated iron levels, work with your healthcare provider to develop a comprehensive testing and monitoring plan. This should include regular blood work to track iron markers, assessment for underlying conditions, genetic testing if appropriate, and implementation of treatment strategies based on the identified cause. Remember that many people with high iron levels live normal, healthy lives with proper management. The most important step is identifying the cause and taking appropriate action to protect your health.

References

  1. Adams PC, Barton JC. How I treat hemochromatosis. Blood. 2010;116(3):317-325.[Link][PubMed][DOI]
  2. Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nature Reviews Cancer. 2013;13(5):342-355.[Link][PubMed][DOI]
  3. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(1):328-343.[PubMed][DOI]
  4. Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG Clinical Guideline: Hereditary Hemochromatosis. American Journal of Gastroenterology. 2019;114(8):1202-1218.[PubMed][DOI]
  5. Brissot P, Pietrangelo A, Adams PC, de Graaff B, McLaren CE, Loréal O. Haemochromatosis. Nature Reviews Disease Primers. 2018;4:18016.[PubMed][DOI]
  6. Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Reviews. 2009;23(3):95-104.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ferritin at home?

You can test your ferritin at home with SiPhox Health's Core Health Program, which includes ferritin testing along with other essential biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home.

What ferritin level indicates cancer?

There's no specific ferritin level that definitively indicates cancer. While levels above 1,000 ng/mL warrant investigation, many non-cancerous conditions can cause similar elevations. Cancer diagnosis requires comprehensive testing beyond iron markers alone.

Can high iron levels be reversed?

Yes, high iron levels can often be effectively managed or reversed depending on the cause. Hereditary hemochromatosis responds well to phlebotomy, while addressing underlying liver disease or stopping excessive supplementation can normalize levels in other cases.

How quickly can iron levels change?

Serum iron can fluctuate within hours based on meals and time of day. Ferritin changes more slowly, typically over weeks to months. With treatment like phlebotomy, ferritin may drop 30-50 ng/mL per session, while dietary changes produce gradual changes over months.

Should I stop taking iron supplements if my levels are high?

If testing shows elevated iron levels, you should stop iron supplements and consult your healthcare provider immediately. Never stop prescribed medications without medical guidance, but over-the-counter iron supplements should be discontinued until the cause is determined.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details